BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30957525)

  • 1. HIV Anxiety Reduction/Management Program (HAMRT): pilot randomized controlled trial.
    Brandt CP; Paulus DJ; Lopez-Gamundi P; Green C; Lemaire C; Zvolensky MJ
    AIDS Care; 2019 Dec; 31(12):1527-1532. PubMed ID: 30957525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Initial Open Trial of a Brief Behavioral Activation Treatment for Depression and Medication Adherence in HIV-Infected Patients.
    Tull MT; Berghoff CR; Bardeen JR; Schoenleber M; Konkle-Parker DJ
    Behav Modif; 2018 Mar; 42(2):196-209. PubMed ID: 28799413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cluster randomised controlled trial protocol of an adapted intervention for alcohol use disorders in people living with HIV and AIDS: impact on alcohol use, general functional ability, quality of life and adherence to HAART.
    Madhombiro M; Dube-Marimbe B; Dube M; Chibanda D; Zunza M; Rusakaniko S; Stewart D; Seedat S
    BMC Psychiatry; 2017 Jan; 17(1):44. PubMed ID: 28129756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Nurse-Delivered Cognitive Behavioral Intervention on Depression and Anxiety for Persons Living With HIV in China: A Clinical Controlled Trial.
    Han S; Hu Y; Relf MV; Mulawa MI; Lu H; Zhang L; Zhu Z; Luo J; Pei Y; Wu B
    J Assoc Nurses AIDS Care; 2021 Jan-Feb 01; 32(1):79-93. PubMed ID: 33177434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the Kigali Imbereheza Project: A 2-Arm Individually Randomized Trial of TI-CBT Enhanced to Address ART Adherence and Mental Health for Rwandan Youth Living With HIV.
    Donenberg GR; Fitts J; Ingabire C; Nsanzimana S; Fabri M; Emerson E; Remera E; Manzi O; Bray B; Cohen MH
    J Acquir Immune Defic Syndr; 2022 May; 90(1):69-78. PubMed ID: 35013089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental health disorders and substance use among people living with HIV in Nepal: their influence on non-adherence to anti-retroviral therapy.
    Pokhrel KN; Pokhrel KG; Sharma VD; Poudel KC; Neupane SR; Mlunde LB; Jimba M
    AIDS Care; 2019 Aug; 31(8):923-931. PubMed ID: 30835503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive behavioral therapy for persons living with HIV in China: A randomized pilot trial.
    Han S; Hu Y; Lu H; Zhang L; Zhu Z; Luo J; Relf MV; Mulawa MI; Pei Y; Wu B
    J Affect Disord; 2020 Dec; 277():640-648. PubMed ID: 32911214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and Acceptability of a Task-Shifted Intervention to Enhance Adherence to HIV Medication and Improve Depression in People Living with HIV in Zimbabwe, a Low Income Country in Sub-Saharan Africa.
    Abas M; Nyamayaro P; Bere T; Saruchera E; Mothobi N; Simms V; Mangezi W; Macpherson K; Croome N; Magidson J; Makadzange A; Safren S; Chibanda D; O'Cleirigh C
    AIDS Behav; 2018 Jan; 22(1):86-101. PubMed ID: 28063075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of Change in Cognitive Behavioral Therapy for Body Image and Self-Care on ART Adherence Among Sexual Minority Men Living with HIV.
    Lamb KM; Nogg KA; Safren SA; Blashill AJ
    AIDS Behav; 2018 Aug; 22(8):2711-2717. PubMed ID: 29752620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial.
    Safren SA; Bedoya CA; O'Cleirigh C; Biello KB; Pinkston MM; Stein MD; Traeger L; Kojic E; Robbins GK; Lerner JA; Herman DS; Mimiaga MJ; Mayer KH
    Lancet HIV; 2016 Nov; 3(11):e529-e538. PubMed ID: 27658881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Acceptability of a Mindfulness-Based Cognitive Therapy Intervention for African-American Women Living with HIV/AIDS.
    Hunter-Jones JJ; Gilliam SM; Carswell AL; Hansen NB
    J Racial Ethn Health Disparities; 2019 Dec; 6(6):1157-1166. PubMed ID: 31332688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiety, depression and treatment adherence among HIV-infected migrants.
    Been SK; Schadé A; Bassant N; Kastelijns M; Pogány K; Verbon A
    AIDS Care; 2019 Aug; 31(8):979-987. PubMed ID: 30957530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Integrated Cognitive-Behavioral Therapy for Anxiety and Medication Adherence Among Persons Living With HIV/AIDS.
    Brandt CP; Paulus DJ; Garza M; Lemaire C; Norton PJ; Zvolensky MJ
    Cogn Behav Pract; 2018 Feb; 25(1):105-118. PubMed ID: 29750006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of a nurse-delivered cognitive behavioral therapy intervention (Ziphamandla) for adherence and depression in HIV in South Africa.
    Andersen LS; Magidson JF; O'Cleirigh C; Remmert JE; Kagee A; Leaver M; Stein DJ; Safren SA; Joska J
    J Health Psychol; 2018 May; 23(6):776-787. PubMed ID: 27121977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying the Exploration Preparation Implementation Sustainment (EPIS) Framework to the Kigali Imbereheza Project for Rwandan Adolescents Living With HIV.
    Donenberg GR; Cohen MH; Ingabire C; Fabri M; Emerson E; Kendall AD; Remera E; Manzi O; Nsanzimana S
    J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 3(Suppl 3):S289-S298. PubMed ID: 31764266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review.
    Springer SA; Dushaj A; Azar MM
    AIDS Behav; 2012 Nov; 16(8):2119-43. PubMed ID: 22644066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study.
    Pence BW; Gaynes BN; Williams Q; Modi R; Adams J; Quinlivan EB; Heine A; Thielman N; Mugavero MJ
    Contemp Clin Trials; 2012 Jul; 33(4):828-38. PubMed ID: 22542960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief cognitive behavior therapy for stigmatization, depression, quality of life, social support and adherence to treatment among patients with HIV/AIDS: a randomized control trial.
    Abbas Q; Nisa M; Khan MU; Anwar N; Aljhani S; Ramzan Z; Shahzadi M
    BMC Psychiatry; 2023 Jul; 23(1):539. PubMed ID: 37491185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of an integrated depression and HIV treatment program on mental health and HIV care outcomes among people newly initiating antiretroviral therapy in Malawi.
    Stockton MA; Udedi M; Kulisewa K; Hosseinipour MC; Gaynes BN; Mphonda SM; Maselko J; Pettifor AE; Verhey R; Chibanda D; Lapidos-Salaiz I; Pence BW
    PLoS One; 2020; 15(5):e0231872. PubMed ID: 32374724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the impact of a community home-based care on mental health and anti-retroviral therapy adherence in people living with HIV in Nepal: a community intervention study.
    Pokhrel KN; Sharma VD; Pokhrel KG; Neupane SR; Mlunde LB; Poudel KC; Jimba M
    BMC Infect Dis; 2018 Jun; 18(1):263. PubMed ID: 29879916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.